1. Malonyl-CoA significantly increased the Km for L-carnitine of overt carnitine palmitoyltransferase in liver mitochondria from fed rats. This effect was observed when the molar palmitoyl-CoA/albumin concentration ratio was low (0.125-1.0), but not when it was higher (2.0). In the absence of malonyl-CoA, the Km for L-carnitine increased with increasing palmitoyl-CoA/albumin ratios. 2. Malonyl-CoA did not increase the Km for L-carnitine in liver mitochondria from 24 h-starved rats or in heart mitochondria from fed animals. 3. The Km for L-carnitine of the latent form of carnitine palmitoyltransferase was 3-4 times that for the overt form of the enzyme. 4. At low ratios of palmitoyl-CoA/albumin (0.5), the concentration of malonyl-CoA causing a 50% inhibition of overt carnitine palmitoyltransferase activity was decreased by 30% when assays with liver mitochondria from fed rats were performed at 100 iM-instead of 400 iM-carnitine. Such a decrease was not observed with liver mitochondria from starved animals. 5. L-Carnitine displaced [14C]malonyl-CoA from liver mitochondrial binding sites. D-Carnitine was without effect. L-Carnitine did not displace ['4C]malonyl-CoA from heart mitochondria. 6. It is concluded that, under appropriate conditions, malonyl-CoA may decrease the effectiveness of L-carnitine as a substrate for the enzyme and that L-carnitine may decrease the effectiveness of malonyl-CoA to regulate the enzyme.
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The overt form of carnitine palmitoyltransferase (CPT1) in a number of mammalian tissues shows interesting regulatory properties in that it is strongly inhibited by malonyl-CoA (McGarry et al., 1978; Saggerson & Carpenter, 198 lb, 1982a) and, less potently, by several other short-chain CoA thioesters . The inhibitory effect of malonyl-CoA in liver mitochondria is less pronounced after starvation (Bremer, 1981; Saggerson & Carpenter, 1981a,b; Robinson & Zammit, 1982; Saggerson et al., 1982) . Several studies have shown that the inhibitory effect of malonyl-CoA is interactive with one of the Abbreviations used: CPT1 and CPT,, the overt and latent forms respectively of carnitine palmitoyltransferase (EC 2.3.1.21); ImIx., the maximum inhibition of CPT1 activity by malonyl-CoA; IC50, the concentration of malonyl-CoA causing 50% of max.; '50, the concentration of displacing ligand causing 50% of maximal displacement of bound malonyl-CoA; KD(O , KD(), N, and N, the dissociation constants and maximal binding capacities of high-affinity (1) and low-affinity (2) malonyl-CoA-binding sites.
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substrates of the CPT1 reaction, namely palmitoylCoA (McGarry et al., 1978; Bremer, 1981) . Malonyl-CoA increases the so.5 for palmitoyl-CoA without changing the Vmax (Saggerson & Carpenter, 1981c , 1982b Saggerson, 1982; Saggerson et al., 1982 (Mills et al., , 1984 , heart and liver (Bird & Saggerson, 1984) . The hepatic content of carnitine, the other substrate of CPT1 in the 'physiological' direction, is increased both in short-term ketotic states (3 h after glucagon or anti-insulin serum administration) and in long-term states such as starvation or alloxan-diabetes (McGarry et al., 1975) . Although it has been speculated that the binding sites on CPT1 for carnitine and malonyl-CoA might be closely associated (Mills et al., 1984) , it has also been proposed (McGarry et al., 1977; Veerkamp & Van Moerkerk, 1982 
Chemicals
Sources and treatment of chemicals were as described previously Bird & Saggerson, 1984) .
Isolation of mitochondria
Liver and heart mitochondria were obtained as described by Saggerson (1982) and finally suspended in 0.3M-sucrose medium containing 10mM-Tris/HCl buffer (pH 7.4), 1 mM-EGTA and 1 mMdithiothreitol to give protein concentrations of approx. 6 and 3mg/ml for liver and heart mitochondria respectively. Protein was measured by the method of Lowry et al. (1951) Bird & Saggerson (1984) . Mitochondria were incubated with [2-14C] malonyl-CoA at 0-4°C for 20min in the same medium as was used for assay of CPT, with 20,uM-albumin. Constant binding is achieved within this time (Bird & Saggerson, 1984 Tables 1 shows that when hepatic CPT, from fed rats was assayed with a palmitoyl-CoA/albumin molar ratio of 2.0, 1 OpM-malonyl-CoA did not significantly change the apparent Km for carnitine, confirming previous findings (Saggerson & Carpenter, 1981b) . With a lower ratio of palmitoylCoA/albumin (0.5), lOpM-malonyl-CoA significantly increased the apparent Km for carnitine by 2.2-fold. This effect was seen in the fed, but not in the starved, state. In the fed state the percentage effect of malonyl-CoA on the 'Vmax. (this Vmax.
represents maximal activity at saturating carnitine concentrations, but is not the true Vmax, since [palmitoyl-CoA] cannot be saturating if inhibitory effects of malonyl-CoA are under investigation; Saggerson & Carpenter, 1981 c) was independent of the palmitoyl-CoA/albumin molar ratio, in accord with previous findings (Saggerson & Carpenter, 1982b; Saggerson et al., 1982) . This result also suggests that in liver there may be two components to the malonyl-CoA-mediated inhibition of CPT, activity, namely a carnitine-dependent and a carnitine-independent component. The effect of malonyl-CoA on the Km for carnitine was also investigated in heart mitochondria. Heart CPT1 shows several differences in properties from the liver enzyme (Saggerson & Carpenter, 1981b; Saggerson, 1982; McGarry et al., 1983; Mills et al., 1983) , including considerably greater sensitivity to malonyl-CoA. Table 1 shows that 0.2gM-malonylCoA, which decreased ' max.' by almost 70%, had no effect on the Km for carnitine when the heart enzyme was assayed with a palmitoyl-CoA/ albumin molar ratio of 0.5. Previous work with a partially purified preparation of carnitine palmitoyltransferase has indicated that the kinetics of the reaction with respect to carnitine concentration are highly dependent on the concentration of the second substrate, palmitoyl-CoA (Bremer & Norum, 1967) . It was proposed by Bremer & Norum (1967) that palmitoyl-CoA might affect the apparent Km for carnitine by interacting at a site distinct from the acyl-CoA substrate-binding site. Whether these findings can be extrapolated to CPT, in situ in the mitochondrial membrane is less certain. Nevertheless, it is possible that in the experiments shown in Table I malonyl-CoA could indirectly affect the kinetics with respect to carnitine by competing with, and thereby decreasing, the binding of palmitoyl-CoA. This possibility was investigated by determining the apparent Km of CPT, for carnitine over a wide range of palmitoyl-CoA concentrations in either the presence or the absence of IO uM-malonyl-CoA (Fig. 1) . Several conclusions can be drawn from this experiment. First, in the absence of malonylCoA, the apparent Km for carnitine of CPT, in situ in the mitochondrial membrane was highly dependent on palmitoyl-CoA concentration, particularly at the lower concentrations used. Second, in the absence of malonyl-CoA the estimated Km values were always of the same order as, or lower than, the reported hepatic concentrations of carnitine (McGarry et al., 1975; Long et al., 1982) . Third, lO4tiM-malonyl-CoA modified the effect of palmitoyl-CoA on carnitine kinetics in an unexpected way. Increasing the palmitoyl-CoA/albumin ratio from 0.125 to 0.5 caused an increase in the apparent Km for carnitine, such that the Km value was always 2.2-3.0-fold greater than at corresponding palmitoyl-CoA concentrations in the absence of malonyl-CoA. Under these conditions, the Km for carnitine was raised above normal hepatic carnitine concentrations. However, in the presence of malonyl-CoA, increasing the palmitoyl-CoA/albumin ratio above 0.5 then caused a decrease in the apparent Km for carnitine such that the effect of malonyl-CoA was minimal when the palmitoyl-CoA/albumin ratio reached 2.0. Fourth, the malonyl-CoA-induced increase in the apparent Km for carnitine at low palmitoyl-CoA/albumin ratios cannot be explained by a direct competitive effect of malonyl-CoA versus palmitoyl-CoA.
In standard preparations of intact mitochondria, there is always a small proportion of CPT activity, routinely <15%, that is insensitive to malonylCoA (Saggerson & Carpenter, 198 la; Edwards et al., 1985) . This CPT activity is thought to be due to exposure of CPT2 in damaged mitochondria. In the presence of lOM-malonyl-CoA, the percentage contribution of CPT, to measured CPT activity becomes greater as the palmitoyl-CoA/ albumin ratio is decreased, and this contribution could affect the validity of the results shown in Fig.  1 . Therefore, the following experiment was performed. CPT activity was measured in intact mitochondrial preparations in the presence of 0, 10uM-or 100jM-malonyl-CoA at each of the palmitoyl-CoA and carnitine concentrations shown in Fig. 1 ; 1OOuM-malonyl-CoA was assumed to inhibit CPT, activity completely. In some experiments total CPT activity was also measured in sonicated (2min at 0-50C) mitochondria. The corrected activities of CPT, were taken therefore as: activity at zero malonyl-CoA minus activity at lOOuM-malonyl-CoA for the uninhibited enzyme, and activity at lOiM-malonyl-CoA minus activity at lOOpM-malonyl-CoA for the enzyme inhibited by lOpM-malonyl-CoA. The effect of malonyl-CoA on the apparent Km of CPT, for carnitine at various palmitoyl-CoA/albumin ratios was qualitatively similar to that shown in Fig. 1 , and we conclude that, when the acyl-CoA substrate concentration is low, malonyl-CoA can specifically alter the interaction of carnitine with the active site of hepatic CPT,.
In the above experiment, CPT, activity was estimated as total CPT activity minus CPT1 activity. The apparent Km value of CPT2 for carnitine was 250iM and 415iM at palmitoylCoA/albumin ratios of 0.5 and 2.0 respectively. Thus, as observed previously with brain nonsynaptic mitochondrial CPT (Bird et al., 1985) , the apparent Km of CPT, for carnitine is 3-4-fold greater than that for CPT,. Although precise measurements are lacking, it has been shown that the mitochondrial carnitine concentration is positively correlated with liver carnitine, and the mitochondrial concentration has been estimated as 19OpM (Parvin & Pande, 1979) . The physiological implication of the above findings is that a relatively high Km of CPT2 for carnitine will help to ensure flux of long-chain fatty-acyl groups into the mitochondrial matrix.
From the data shown in Table 1 and Fig. 1 it can be predicted that, at low palmitoyl-CoA/albumin ratios, the effectiveness of malonyl-CoA as an inhibitor of CPT, activity can be modified by the carnitine concentration in assays with liver mitochondria from fed but not from starved rats. This prediction was tested in the experiment shown in Table 2 , which shows that the IC50 for malonylCoA in liver mitochondria of fed animals was 30% lower when assays were performed at 100pM-rather than 400,M-carnitine with a palmitoyl- Table 2 . Influence of carnitine concentration on the inhibition of hepatic CPT1 activity by malonyl-CoA Liver CPT, activity was assayed with 80pM-albumin, 40iM-or 160pM-palmitoyl-CoA and 100pM-or 400pM-carnitine. Malonyl-CoA concentrations were 0, 0.25,0.5,0.75, 1, 2,5, 10,20 and 100pM for assays with mitochondria from fed animals, and 0, 5, 10, 20, 30, 50, 100 and 200pM Fed (3) Starved (3) Fed (2) CoA/albumin ratio of 0.5. This effect was not observed with mitochondria from starved animals, nor when assays with mitochondria from fed animals were conducted with a palmitoyl-CoA/ albumin ratio of 2.0. The data also show that at a palmitoyl-CoA/albumin ratio of 0.5 there was a 17-fold increase in the IC50 for malonyl-CoA on starvation. This contrasts with a 6-fold increase observed previously when assays were conducted in identical conditions but with a palmitoylCoA/albumin ratio of 2.0 (Saggerson & Carpenter, 1981a (Bird & Saggerson, 1984) .
Binding of[14C]malonyl-CoA to intact mitochondria Binding studies were conducted firstly where malonyl-CoA and carnitine were the only ligands in the system. Fig. 2(a) shows that L-carnitine decreased the binding of 0.1 gM-[2-'4C]malonylCoA to liver mitochondria from fed and starved animals. In similar experiments with heart mitochondria L-carnitine was ineffective. The effect seen in liver mitochondria was stereospecific, since D-carnitine was ineffective. Fig. 2(a) in the starved state (n = 7), maximal displacement=43+1% (P<0.02) and 150= 11+lpM (P<0.001). Reciprocal plots of these data (Fig. 2b) indicated that the displacement of ['4C]malonylCoA by L-carnitine was a complex process, suggesting interactions at more than one site. When total malonyl-CoA concentration in binding assays was 1OMm, the concentration-dependence of the displacement of bound malonyl-CoA on Lcarnitine was qualitatively similar to that shown in Fig. 2(a) , giving an 150 value of approx. 25/Mcarnitine, but a maximal displacement of only 22% at 750 pM-carnitine (mean values of two experiments with liver mitochondria from fed rats). Similar values were obtained in experiments with liver mitochondria from starved rats. Since Lcarnitine bears little structural resemblance to malonyl-CoA, it is likely that in liver mitochondria the two compounds bind at independent, but interacting, sites. The nature of these binding sites is unclear, owing to the complexity of malonylCoA binding to intact mitochondrial membranes (Bird & Saggerson, 1984) . Fig. 3 shows that 400 pM-carnitine (which causes approximately maximal displacement of bound malonyl-CoA; see above) decreased malonyl-CoA binding to liver mitochondria from fed animals over a wide range of [malonyl-CoA] . Scatchard plots of the binding data showed pronounced curvature, as observed previously (Bird & Saggerson, 1984) , and were analysed according to a twosite model which may or may not be adequate for Malonyl-CoA bound (pmol/mg of protein) and either 2-bromoacetyl-CoA or 2-bromopalmitoyl-CoA on malonyl-CoA binding to heart mitochondria (see accompanying paper, Edwards et al., 1985) .
General conclusions
This study establishes that at low palmitoylCoA/albumin ratios L-carnitine and malonyl-CoA can specifically interact in the hepatic CPT1 system. On the one hand, malonyl-CoA diminishes the effectiveness of carnitine as a substrate for CPT,. On the other hand, carnitine has effects which might diminish the regulatory effect of malonyl-CoA. The physiological implication of these findings in fed animals is that, by raising the Km of CPT, for carnitine above physiological concentrations of this compound, malonyl-CoA decreases CPT1 activity to a greater extent than expected by direct inhibition of the enzyme alone. In conditions where hepatic carnitine concentrations are acutely increased (e.g. after glucagon or anti-insulin serum administration; McGarry et al., 1975) , malonyl-CoA inhibition of CPT, activity could be partially overcome. For reasons not at present understood, these effects are less pronounced in mitochondria from starved animals, or when the concentration of palmitoyl-CoA is increased. The physical nature of the sites of these interactions and the nature of the starvationinduced change have yet to be established. 
